Hidehisa Iwata

Dr. Hidehisa Iwata

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
MWMasahiro Wakita
Masahiro Wakita
ATAkiko Takahashi
Akiko Takahashi
OSOsamu Sano
Osamu Sano
TLTze Mun Loo
Tze Mun Loo
YIYoshinori Imai
Yoshinori Imai
EHEiji Hara
Eiji Hara
Although cellular senescence acts primarily as a tumour suppression mechanism, the accumulation of senescent cells in vivo eventually exerts deleterious side effects through inflammatory/tumour-promoting factor secretion. Thus, the development of new drugs that cause the specific elimination of senescent cells, termed senolysis, is anticipated. Here, by an unbiased high-throughput screening of chemical compounds and a bio-functional analysis, we identify BET family protein degrader (BETd) as a promising senolytic drug. BETd provokes senolysis through two independent but integrated pathways; the attenuation of non-homologous end joining (NHEJ), and the up-regulation of autophagic gene expression. BETd treatment eliminates senescent hepatic stellate cells in obese mouse livers, accompanied by the reduction of liver cancer development. Furthermore, the elimination of chemotherapy-induced senescent cells by BETd increases the efficacy of chemotherapy against xenograft tumours in immunocompromised mice. These results reveal the vulnerability of senescent cells and open up possibilities for its control.

21 December 2012 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
SSSatoshi Sogabe
Satoshi Sogabe
YKYouichi Kawakita
Youichi Kawakita
SIShigeru Igaki
Shigeru Igaki
HIHidehisa Iwata
Hidehisa Iwata
HMHiroshi Miki
Hiroshi Miki
TITomoyasu Ishikawa
Tomoyasu Ishikawa

24 May 2005 in Nature Chemical Biology
Verified
Journal Article
Closed access
MOMasahiro Okada
Masahiro Okada
ISIsao Sato
Isao Sato
SCSoo Jeong Cho
Soo Jeong Cho
HIHidehisa Iwata
Hidehisa Iwata
TNToshihiko Nishio
Toshihiko Nishio
YSYouji Sakagami
Youji Sakagami

1 October 2010 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
YOYuya Oguro
Yuya Oguro
NMNaoki Miyamoto
Naoki Miyamoto
KOKengo Okada
Kengo Okada
TTTerufumi Takagi
Terufumi Takagi
HIHidehisa Iwata
Hidehisa Iwata
SIShinichi Imamura
Shinichi Imamura

2 May 2016 in FEBS Letters
Verified
Journal Article
Open access
PDF file
OSOsamu Sano
Osamu Sano
KKKenichi Kazetani
Kenichi Kazetani
MFMasaaki Funata
Masaaki Funata
YFYasunori Fukuda
Yasunori Fukuda
JMJunji Matsui
Junji Matsui
HIHidehisa Iwata
Hidehisa Iwata
Lysosomal protein degradation via autophagy strictly regulates cellular protein homoeostasis. Herein we performed high‐content screening to identify compounds that inhibit autophagy pathways. We obtained 11 hit compounds and performed cluster analysis using cellular morphological information. Vacuolin‐1, which induces the formation of giant vacuoles and is a target unknown compound, clustered with the known PIKfyve inhibitor YM201636. We further confirmed that vacuolin‐1 is a potent PIKfyve inhibitor, and we finally concluded that PIKfyve inhibitors are novel chemical tools for regulating autophagy.

1 April 2013 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
YKYouichi Kawakita
Youichi Kawakita
MSMasaki Seto
Masaki Seto
TOTomohiro Ohashi
Tomohiro Ohashi
TTToshiya Tamura
Toshiya Tamura
TYTadashi Yusa
Tadashi Yusa
TITomoyasu Ishikawa
Tomoyasu Ishikawa